NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 74 filers reported holding NGM BIOPHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $74,838 | -75.5% | 28,895 | -61.3% | 0.01% | -75.6% |
| Q1 2023 | $304,849 | -41.8% | 74,718 | -28.4% | 0.04% | -51.8% |
| Q4 2022 | $524,003 | +17.0% | 104,383 | +204.6% | 0.08% | +25.0% |
| Q3 2022 | $448,000 | -23.0% | 34,267 | -10.2% | 0.07% | +36.0% |
| Q1 2022 | $582,000 | -42.9% | 38,179 | -33.7% | 0.05% | -35.9% |
| Q4 2021 | $1,019,000 | -10.6% | 57,546 | +6.1% | 0.08% | -4.9% |
| Q3 2021 | $1,140,000 | +59.7% | 54,246 | +49.9% | 0.08% | +74.5% |
| Q2 2021 | $714,000 | +340.7% | 36,200 | +175.3% | 0.05% | +261.5% |
| Q1 2020 | $162,000 | – | 13,150 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 3,766,666 | $59,928,000 | 49.90% |
| Greenspring Associates, LLC | 1,573,357 | $25,032,000 | 38.95% |
| Svennilson Peter | 18,017,932 | $286,665,000 | 23.39% |
| Aquilo Capital Management, LLC | 1,018,334 | $16,202,000 | 1.72% |
| Jasper Ridge Partners, L.P. | 308,750 | $4,912,000 | 0.28% |
| Samsara BioCapital, LLC | 36,451 | $580,000 | 0.16% |
| Rock Springs Capital Management LP | 360,454 | $5,735,000 | 0.15% |
| Point72 Asset Management, L.P. | 1,611,850 | $25,645,000 | 0.13% |
| Virtus ETF Advisers LLC | 14,880 | $237,000 | 0.12% |
| WELD CAPITAL MANAGEMENT LLC | 15,238 | $242,000 | 0.10% |